Spain Pharmaceuticals and Healthcare Report Q2 2014

Business Monitor International
March 26, 2014
101 Pages - SKU: BMI5222040
Countries covered: Spain

Spain Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Despite the Spanish economy returning to growth in 2014, the country's pharmaceuticals andhealthcare sectors show no sign of following suit. The Spanish government's ongoing cash flow troublesand aggressive fiscal austerity measures, which focus heavily on cost containment in the healthcare sector,will continue to negatively impact pharmaceutical companies operating in Spain.

Headline Expenditure Projections

Pharmaceuticals: EUR24.09bn (US$31.79bn) in 2013 to EUR22.81bn (US$28.97bn) in 2014; -5.3% inlocal currency terms and -8.9% in US dollar terms.

Healthcare: EUR98.71bn (US$130.30bn) in 2013 to EUR98.57bn (US$125.19bn) in 2014; -0.1% inlocal currency terms and -3.9% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More Spain Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Spain Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Spain Q4 2014BMI View: Despite the Spanish economy returning to growth in 2014 and picking up steam heading into2015, we ...
Pharmaceuticals and Healthcare Report Q3 2014 - Spain by Business Monitor International
Spain Pharmaceuticals and Healthcare Report Q3 2014BMI View: The weakened Spanish economy and the government's ongoing multi-faceted strategy to containexpenditure on prescription medicines by targeting ...
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022SummarySchizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core ...
Pharmaceuticals in Spain: ISIC 2423 by Euromonitor International
Pharmaceuticals in Spain: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!